AG
AIMT

Artal Group’s Aimmune Therapeutics, Inc. AIMT Stock Holding History

Artal Group’s Portfolio AIMT Stock Details AIMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100,000
Closed -$2.06M – 104
2017
Q2 		$2.06M Sell
100,000
-81,600
-45% -$1.68M 0.04% 69
2017
Q1 		$3.95M Buy
181,600
+100,000
+123% +$2.17M 0.09% 47
2016
Q4 		$1.67M Buy
+81,600
New +$1.67M 0.04% 51